Globe Life Inc. (NYSE:GL – Get Free Report) CFO Thomas Peter Kalmbach sold 7,936 shares of Globe Life stock in a transaction dated Friday, May 22nd. The stock was sold at an average price of $156.59, for a total transaction of $1,242,698.24. Following the completion of the transaction, the chief financial officer owned 50,496 shares of the company’s stock, valued at $7,907,168.64. The trade was a 13.58% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.
Thomas Peter Kalmbach also recently made the following trade(s):
- On Tuesday, May 19th, Thomas Peter Kalmbach sold 11,903 shares of Globe Life stock. The stock was sold at an average price of $156.61, for a total transaction of $1,864,128.83.
- On Friday, May 8th, Thomas Peter Kalmbach sold 11,790 shares of Globe Life stock. The stock was sold at an average price of $152.02, for a total transaction of $1,792,315.80.
- On Monday, May 11th, Thomas Peter Kalmbach sold 15,637 shares of Globe Life stock. The shares were sold at an average price of $153.65, for a total transaction of $2,402,625.05.
Globe Life Price Performance
GL stock opened at $153.88 on Friday. The firm has a 50 day moving average of $148.53 and a 200-day moving average of $142.63. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.38. Globe Life Inc. has a 12 month low of $116.73 and a 12 month high of $157.92. The firm has a market capitalization of $11.95 billion, a P/E ratio of 10.64 and a beta of 0.50.
Globe Life Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Monday, July 6th will be given a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date is Monday, July 6th. Globe Life’s dividend payout ratio (DPR) is 9.13%.
Analysts Set New Price Targets
A number of research firms have recently commented on GL. Texas Capital upgraded shares of Globe Life to a “strong-buy” rating in a research report on Wednesday, March 18th. Weiss Ratings upgraded shares of Globe Life from a “buy (b-)” rating to a “buy (b)” rating in a research report on Wednesday, May 13th. Evercore set a $157.00 target price on shares of Globe Life in a research report on Wednesday, February 18th. Morgan Stanley lifted their target price on shares of Globe Life from $176.00 to $181.00 and gave the company an “overweight” rating in a research report on Thursday, May 21st. Finally, Keefe, Bruyette & Woods reiterated a “moderate buy” rating and set a $168.00 target price on shares of Globe Life in a research report on Thursday, March 26th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $174.11.
View Our Latest Stock Analysis on Globe Life
Institutional Inflows and Outflows
Large investors have recently made changes to their positions in the business. CYBER HORNET ETFs LLC purchased a new position in shares of Globe Life during the second quarter worth approximately $28,000. Hilton Head Capital Partners LLC purchased a new position in shares of Globe Life during the fourth quarter worth approximately $30,000. MUFG Securities EMEA plc purchased a new position in shares of Globe Life during the second quarter worth approximately $31,000. Torren Management LLC purchased a new position in shares of Globe Life during the fourth quarter worth approximately $37,000. Finally, Root Financial Partners LLC purchased a new position in shares of Globe Life during the third quarter worth approximately $44,000. 81.61% of the stock is owned by hedge funds and other institutional investors.
About Globe Life
Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.
The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.
Read More
- Five stocks we like better than Globe Life
- 3 Stocks Rallying on Micron’s Price Boost: Substance or Hype?
- Snowflake and the Snowballing Impact of its AI Flywheel
- AI’s Biggest Bottleneck Could Make These 2 Stocks Soar
- These 3 Beaten-Down Stocks Just Saw $25 Million in Insider Buying
Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.
